SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-040761
Filing Date
2021-08-06
Accepted
2021-08-06 16:01:21
Documents
1
Period of Report
2021-08-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6391
  Complete submission text file 0001213900-21-040761.txt   7953
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address MAXIM GROUP, LLC 405 LEXINGTON AVENUE NEW YORK NY 10174
Business Address
Rabinowitz Michael (Reporting) CIK: 0001767090 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 211152815